person · Reporting owner

LaCasce Carl E.

Disclosed activity across 1 company

Tapewire entity: 165928
SEC CIK: 0001695298

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
Varex Imaging CorpVREX · Entity 5135	SVP, Sales & Marketing	June 05, 2018	June 07, 2018

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Varex Imaging Corp

Report date June 05, 2018 · Filed June 07, 2018

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	27,971	Reported balance After 2018-06-05 transaction · row 1 Account or security details depend on footnotes; rows are not merged. 1 source row Row 1 · 2018-06-05 · Exercise / conversion · Acquired 11,155 · Balance 27,971 F1: Amount of securities beneficially owned at end of reporting period reflect 236 shares purchased on April 27, 2018 under the Varex Imaging Corporation 2017 Employee Stock Purchase Plan.
Common StockSEC Table I · non-derivative	Direct	16,816	Reported balance After 2018-06-05 transaction · row 2 Account or security details depend on footnotes; rows are not merged. 1 source row Row 2 · 2018-06-05 · Sale · Disposed 11,155 · Balance 16,816 F2: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person on March 14, 2018. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.15 to $37.86.
Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $19.21 · Expires 2018-11-11	Direct	0	Reported balance After 2018-06-05 transaction · row 3 Instrument identity requires review; Table II rows are not merged. 1 source row Row 3 · 2018-06-05 · Exercise / conversion · Disposed 11,155 · Balance 0 F3: These options were granted in connection with the spin-off from Varian Medical Systems, Inc. and were immediately exercisable because they replaced Varian options that had previously vested.

Filing footnotes · ownership attribution and instrument terms

F1: Amount of securities beneficially owned at end of reporting period reflect 236 shares purchased on April 27, 2018 under the Varex Imaging Corporation 2017 Employee Stock Purchase Plan.

F2: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person on March 14, 2018. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.15 to $37.86.

F3: These options were granted in connection with the spin-off from Varian Medical Systems, Inc. and were immediately exercisable because they replaced Varian options that had previously vested.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
June 05, 2018 Filed Jun 7, 2018 17:16 UTC	Varex Imaging Corp VREX · Entity 5135	Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative	11,155	$0.00 Strike: $19.21	$0.00	Disclosure SEC source: 0001681622-18-000020 · wf-form4_152840619676269.xml · derivative · entry 3 LaCasce Carl E. · CIK 0001695298 · SVP, Sales & Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 11,155 shares Expires 2018-11-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: These options were granted in connection with the spin-off from Varian Medical Systems, Inc. and were immediately exercisable because they replaced Varian options that had previously vested. Read SEC document
June 05, 2018 Filed Jun 7, 2018 17:16 UTC	Varex Imaging Corp VREX · Entity 5135	SaleCommon Stock	11,155	$37.42	$417,400.02	Disclosure SEC source: 0001681622-18-000020 · wf-form4_152840619676269.xml · nonDerivative · entry 2 LaCasce Carl E. · CIK 0001695298 · SVP, Sales & Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,816 F2 · price: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person on March 14, 2018. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.15 to $37.86. Read SEC document
June 05, 2018 Filed Jun 7, 2018 17:16 UTC	Varex Imaging Corp VREX · Entity 5135	Exercise / conversionCommon Stock	11,155	$19.21	$214,287.55	Disclosure SEC source: 0001681622-18-000020 · wf-form4_152840619676269.xml · nonDerivative · entry 1 LaCasce Carl E. · CIK 0001695298 · SVP, Sales & Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,971 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Amount of securities beneficially owned at end of reporting period reflect 236 shares purchased on April 27, 2018 under the Varex Imaging Corporation 2017 Employee Stock Purchase Plan. Read SEC document
February 15, 2018 Filed Feb 20, 2018 20:50 UTC	Varex Imaging Corp VREX · Entity 5135	GrantNon-Qualified Stock Option (right to buy) · Derivative	15,095	$0.00 Strike: $37.10	$0.00	Disclosure SEC source: 0001214659-18-001418 · marketforms-41072.xml · derivative · entry 9 LaCasce Carl E. · CIK 0001695298 · SVP, Sales & Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,095 Underlying: Common Stock · 15,095 shares Expires 2025-02-16 F8 · derivative.exercise_date: This Non-Qualified Stock Option is subject to a four-year vesting schedule. 25% of the total number of options vests one year from grant date, and the remaining options vests monthly thereafter on a pro rata basis. Read SEC document
February 15, 2018 Filed Feb 20, 2018 20:50 UTC	Varex Imaging Corp VREX · Entity 5135	GrantRestricted Stock Units · Derivative	4,805	$0.00	$0.00	Disclosure SEC source: 0001214659-18-001418 · marketforms-41072.xml · derivative · entry 8 LaCasce Carl E. · CIK 0001695298 · SVP, Sales & Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,805 Underlying: Common Stock · 4,805 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. F7 · derivative.exercise_date: The Restricted Stock Units granted on February 15, 2018 vest 25% each year for four years beginning on February 15, 2019. Vested shares will be delivered to the reporting person upon vest date. F7 · derivative.expiration_date: The Restricted Stock Units granted on February 15, 2018 vest 25% each year for four years beginning on February 15, 2019. Vested shares will be delivered to the reporting person upon vest date. Read SEC document
February 15, 2018 Filed Feb 20, 2018 20:50 UTC	Varex Imaging Corp VREX · Entity 5135	Exercise / conversionRestricted Stock Units · Derivative	1,664	$0.00	$0.00	Disclosure SEC source: 0001214659-18-001418 · marketforms-41072.xml · derivative · entry 7 LaCasce Carl E. · CIK 0001695298 · SVP, Sales & Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,664 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. F6 · derivative.exercise_date: These Restricted Stock Units vest in two equal annual installments with the first vesting date being February 15, 2017. Vested shares will be delivered to the reporting person upon vest date. F6 · derivative.expiration_date: These Restricted Stock Units vest in two equal annual installments with the first vesting date being February 15, 2017. Vested shares will be delivered to the reporting person upon vest date. Read SEC document
February 15, 2018 Filed Feb 20, 2018 20:50 UTC	Varex Imaging Corp VREX · Entity 5135	Exercise / conversionRestricted Stock Units · Derivative	1,766	$0.00	$0.00	Disclosure SEC source: 0001214659-18-001418 · marketforms-41072.xml · derivative · entry 6 LaCasce Carl E. · CIK 0001695298 · SVP, Sales & Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,767 Underlying: Common Stock · 1,766 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. F5 · derivative.exercise_date: These Restricted Stock Units vest in three equal annual installments with the first vesting date being February 15, 2017. Vested shares will be delivered to the reporting person upon vest date. F5 · derivative.expiration_date: These Restricted Stock Units vest in three equal annual installments with the first vesting date being February 15, 2017. Vested shares will be delivered to the reporting person upon vest date. Read SEC document
February 15, 2018 Filed Feb 20, 2018 20:50 UTC	Varex Imaging Corp VREX · Entity 5135	Exercise / conversionRestricted Stock Units · Derivative	1,592	$0.00	$0.00	Disclosure SEC source: 0001214659-18-001418 · marketforms-41072.xml · derivative · entry 5 LaCasce Carl E. · CIK 0001695298 · SVP, Sales & Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,479 Underlying: Common Stock · 1,592 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. F4 · derivative.exercise_date: These Restricted Stock Units vest 25% each year for four years with the first vesting date being February 15, 2018. Vested shares will be delivered to the reporting person upon vest date. F4 · derivative.expiration_date: These Restricted Stock Units vest 25% each year for four years with the first vesting date being February 15, 2018. Vested shares will be delivered to the reporting person upon vest date. Read SEC document
February 15, 2018 Filed Feb 20, 2018 20:50 UTC	Varex Imaging Corp VREX · Entity 5135	Tax withholdingCommon Stock	1,529	$37.10	$56,725.90	Disclosure SEC source: 0001214659-18-001418 · marketforms-41072.xml · nonDerivative · entry 4 LaCasce Carl E. · CIK 0001695298 · SVP, Sales & Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,580 F3 · shares: These shares represent shares withheld for satisfaction of a tax withholding obligation arising as a result of the vesting of the Restricted Stock Units reported herein. Read SEC document
February 15, 2018 Filed Feb 20, 2018 20:50 UTC	Varex Imaging Corp VREX · Entity 5135	Exercise / conversionCommon Stock	1,664	Not disclosed	Not disclosed	Disclosure SEC source: 0001214659-18-001418 · marketforms-41072.xml · nonDerivative · entry 3 LaCasce Carl E. · CIK 0001695298 · SVP, Sales & Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,109 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. Read SEC document
February 15, 2018 Filed Feb 20, 2018 20:50 UTC	Varex Imaging Corp VREX · Entity 5135	Exercise / conversionCommon Stock	1,766	Not disclosed	Not disclosed	Disclosure SEC source: 0001214659-18-001418 · marketforms-41072.xml · nonDerivative · entry 2 LaCasce Carl E. · CIK 0001695298 · SVP, Sales & Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,445 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. Read SEC document
February 15, 2018 Filed Feb 20, 2018 20:50 UTC	Varex Imaging Corp VREX · Entity 5135	Exercise / conversionCommon Stock	1,592	Not disclosed	Not disclosed	Disclosure SEC source: 0001214659-18-001418 · marketforms-41072.xml · nonDerivative · entry 1 LaCasce Carl E. · CIK 0001695298 · SVP, Sales & Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,679 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. F2 · balance_after: Includes 229 shares acquired under the Varex Imaging Corporation 2017 Employee Stock Purchase Plan Read SEC document
February 28, 2017 Filed Mar 2, 2017 15:55 UTC	Varex Imaging Corp VREX · Entity 5135	Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative	18,089	$0.00 Strike: $17.53	$0.00	Disclosure SEC source: 0001214659-17-001583 · marketforms-38130.xml · derivative · entry 3 LaCasce Carl E. · CIK 0001695298 · SVP, Sales & Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 18,089 shares Expires 2017-05-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option is immediately exercisable. Read SEC document
February 28, 2017 Filed Mar 2, 2017 15:55 UTC	Varex Imaging Corp VREX · Entity 5135	SaleCommon Stock	18,089	$35.00	$633,087.87	Disclosure SEC source: 0001214659-17-001583 · marketforms-38130.xml · nonDerivative · entry 2 LaCasce Carl E. · CIK 0001695298 · SVP, Sales & Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,530 F1 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.29 to $34.26. Read SEC document
February 28, 2017 Filed Mar 2, 2017 15:55 UTC	Varex Imaging Corp VREX · Entity 5135	Exercise / conversionCommon Stock	18,089	$17.53	$317,100.17	Disclosure SEC source: 0001214659-17-001583 · marketforms-38130.xml · nonDerivative · entry 1 LaCasce Carl E. · CIK 0001695298 · SVP, Sales & Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,619 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
February 16, 2017 Filed Feb 17, 2017 20:30 UTC	Varex Imaging Corp VREX · Entity 5135	GrantNon-Qualified Stock Option (right to buy) · Derivative	67,450	$0.00 Strike: $31.08	$0.00	Disclosure SEC source: 0001214659-17-001255 · marketforms-37978.xml · derivative · entry 11 LaCasce Carl E. · CIK 0001695298 · SVP, Sales & Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,450 Underlying: Common Stock · 67,450 shares Expires 2024-02-16 F7 · derivative.exercise_date: This Non-Qualified Stock Option is subject to a four-year vesting schedule. 25% of the total number of shares vests one year from grant date, and the remaining 75% vests monthly thereafter. Read SEC document
February 16, 2017 Filed Feb 17, 2017 20:30 UTC	Varex Imaging Corp VREX · Entity 5135	GrantRestricted Stock Units · Derivative	6,371	$0.00	$0.00	Disclosure SEC source: 0001214659-17-001255 · marketforms-37978.xml · derivative · entry 10 LaCasce Carl E. · CIK 0001695298 · SVP, Sales & Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,568 Underlying: Common Stock · 6,370 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. F6 · derivative.exercise_date: The Restricted Stock Units granted on February 16, 2017 vest 25% each year for four years beginning on February 15, 2018. Vested shares will be delivered to the reporting person upon vest date. F6 · derivative.expiration_date: The Restricted Stock Units granted on February 16, 2017 vest 25% each year for four years beginning on February 15, 2018. Vested shares will be delivered to the reporting person upon vest date. Read SEC document
February 15, 2017 Filed Feb 17, 2017 20:30 UTC	Varex Imaging Corp VREX · Entity 5135	Exercise / conversionRestricted Stock Units · Derivative	1,767	$0.00	$0.00	Disclosure SEC source: 0001214659-17-001255 · marketforms-37978.xml · derivative · entry 9 LaCasce Carl E. · CIK 0001695298 · SVP, Sales & Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,533 Underlying: Common Stock · 1,767 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. F5 · derivative.exercise_date: These Restricted Stock Units vest in three equal annual installments beginning February 15, 2017. Vested shares will be delivered to the reporting person upon vest date. F5 · derivative.expiration_date: These Restricted Stock Units vest in three equal annual installments beginning February 15, 2017. Vested shares will be delivered to the reporting person upon vest date. Read SEC document
February 15, 2017 Filed Feb 17, 2017 20:30 UTC	Varex Imaging Corp VREX · Entity 5135	Exercise / conversionRestricted Stock Units · Derivative	1,664	$0.00	$0.00	Disclosure SEC source: 0001214659-17-001255 · marketforms-37978.xml · derivative · entry 8 LaCasce Carl E. · CIK 0001695298 · SVP, Sales & Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,664 Underlying: Common Stock · 1,664 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. F4 · derivative.exercise_date: These Restricted Stock Units vest in two equal annual installments beginning February 15, 2017. Vested shares will be delivered to the reporting person upon vest date. F4 · derivative.expiration_date: These Restricted Stock Units vest in two equal annual installments beginning February 15, 2017. Vested shares will be delivered to the reporting person upon vest date. Read SEC document
February 15, 2017 Filed Feb 17, 2017 20:30 UTC	Varex Imaging Corp VREX · Entity 5135	Exercise / conversionRestricted Stock Units · Derivative	4,323	$0.00	$0.00	Disclosure SEC source: 0001214659-17-001255 · marketforms-37978.xml · derivative · entry 7 LaCasce Carl E. · CIK 0001695298 · SVP, Sales & Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,323 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. F3 · derivative.exercise_date: These Restricted Stock Units vest February 15, 2017. Vested shares will be delivered to the reporting person upon vest date. F3 · derivative.expiration_date: These Restricted Stock Units vest February 15, 2017. Vested shares will be delivered to the reporting person upon vest date. Read SEC document
February 15, 2017 Filed Feb 17, 2017 20:30 UTC	Varex Imaging Corp VREX · Entity 5135	Exercise / conversionRestricted Stock Units · Derivative	2,002	$0.00	$0.00	Disclosure SEC source: 0001214659-17-001255 · marketforms-37978.xml · derivative · entry 6 LaCasce Carl E. · CIK 0001695298 · SVP, Sales & Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,002 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. F3 · derivative.exercise_date: These Restricted Stock Units vest February 15, 2017. Vested shares will be delivered to the reporting person upon vest date. F3 · derivative.expiration_date: These Restricted Stock Units vest February 15, 2017. Vested shares will be delivered to the reporting person upon vest date. Read SEC document
February 15, 2017 Filed Feb 17, 2017 20:30 UTC	Varex Imaging Corp VREX · Entity 5135	Tax withholdingCommon Stock	3,226	$29.93	$96,554.18	Disclosure SEC source: 0001214659-17-001255 · marketforms-37978.xml · nonDerivative · entry 5 LaCasce Carl E. · CIK 0001695298 · SVP, Sales & Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,530 F2 · shares: These shares represent shares withheld for satisfaction of a tax withholding obligation arising as a result of the vesting of the Restricted Stock Units reported herein. Read SEC document
February 15, 2017 Filed Feb 17, 2017 20:30 UTC	Varex Imaging Corp VREX · Entity 5135	Exercise / conversionCommon Stock	1,767	Not disclosed	Not disclosed	Disclosure SEC source: 0001214659-17-001255 · marketforms-37978.xml · nonDerivative · entry 4 LaCasce Carl E. · CIK 0001695298 · SVP, Sales & Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,756 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. Read SEC document
February 15, 2017 Filed Feb 17, 2017 20:30 UTC	Varex Imaging Corp VREX · Entity 5135	Exercise / conversionCommon Stock	1,664	Not disclosed	Not disclosed	Disclosure SEC source: 0001214659-17-001255 · marketforms-37978.xml · nonDerivative · entry 3 LaCasce Carl E. · CIK 0001695298 · SVP, Sales & Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,989 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. Read SEC document
February 15, 2017 Filed Feb 17, 2017 20:30 UTC	Varex Imaging Corp VREX · Entity 5135	Exercise / conversionCommon Stock	4,323	Not disclosed	Not disclosed	Disclosure SEC source: 0001214659-17-001255 · marketforms-37978.xml · nonDerivative · entry 2 LaCasce Carl E. · CIK 0001695298 · SVP, Sales & Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,325 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. Read SEC document
February 15, 2017 Filed Feb 17, 2017 20:30 UTC	Varex Imaging Corp VREX · Entity 5135	Exercise / conversionCommon Stock	2,002	Not disclosed	Not disclosed	Disclosure SEC source: 0001214659-17-001255 · marketforms-37978.xml · nonDerivative · entry 1 LaCasce Carl E. · CIK 0001695298 · SVP, Sales & Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,002 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. Read SEC document
January 28, 2017 Filed Jan 31, 2017 21:03 UTC	Varex Imaging Corp VREX · Entity 5135	GrantRestricted Stock Units · Derivative	0	$0.00	$0.00	Disclosure SEC source: 0001214659-17-000583 · marketforms-37693.xml · derivative · entry 10 LaCasce Carl E. · CIK 0001695298 · SVP, Sales & Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · Not disclosed shares Expires not disclosed F8 · derivative.exercise_price: In connection with the Spin-off, each outstanding deferred stock unit ("RSU") award held by the reporting person was converted into a RSU award denominated in shares of the Issuer's common stock. The number of shares underlying the RSU award will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian RSU award. Once the number of shares of the Issuer's common stock underlying this RSU award has been determined, an amended Form 4 will be filed disclosing such information. Each RSU represents a contingent right to receive one share of the Issuer's underlying common stock. F8 · shares: In connection with the Spin-off, each outstanding deferred stock unit ("RSU") award held by the reporting person was converted into a RSU award denominated in shares of the Issuer's common stock. The number of shares underlying the RSU award will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian RSU award. Once the number of shares of the Issuer's common stock underlying this RSU award has been determined, an amended Form 4 will be filed disclosing such information. Each RSU represents a contingent right to receive one share of the Issuer's underlying common stock. F11 · derivative.exercise_date: These RSUs vest in three equal annual installments beginning on February 12, 2017. Vested shares will be delivered to the reporting person upon vest date. F11 · derivative.expiration_date: These RSUs vest in three equal annual installments beginning on February 12, 2017. Vested shares will be delivered to the reporting person upon vest date. F8 · derivative.underlying_shares: In connection with the Spin-off, each outstanding deferred stock unit ("RSU") award held by the reporting person was converted into a RSU award denominated in shares of the Issuer's common stock. The number of shares underlying the RSU award will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian RSU award. Once the number of shares of the Issuer's common stock underlying this RSU award has been determined, an amended Form 4 will be filed disclosing such information. Each RSU represents a contingent right to receive one share of the Issuer's underlying common stock. F8 · balance_after: In connection with the Spin-off, each outstanding deferred stock unit ("RSU") award held by the reporting person was converted into a RSU award denominated in shares of the Issuer's common stock. The number of shares underlying the RSU award will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian RSU award. Once the number of shares of the Issuer's common stock underlying this RSU award has been determined, an amended Form 4 will be filed disclosing such information. Each RSU represents a contingent right to receive one share of the Issuer's underlying common stock. Read SEC document
January 28, 2017 Filed Jan 31, 2017 21:03 UTC	Varex Imaging Corp VREX · Entity 5135	GrantRestricted Stock Units · Derivative	0	$0.00	$0.00	Disclosure SEC source: 0001214659-17-000583 · marketforms-37693.xml · derivative · entry 9 LaCasce Carl E. · CIK 0001695298 · SVP, Sales & Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · Not disclosed shares Expires not disclosed F8 · derivative.exercise_price: In connection with the Spin-off, each outstanding deferred stock unit ("RSU") award held by the reporting person was converted into a RSU award denominated in shares of the Issuer's common stock. The number of shares underlying the RSU award will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian RSU award. Once the number of shares of the Issuer's common stock underlying this RSU award has been determined, an amended Form 4 will be filed disclosing such information. Each RSU represents a contingent right to receive one share of the Issuer's underlying common stock. F8 · shares: In connection with the Spin-off, each outstanding deferred stock unit ("RSU") award held by the reporting person was converted into a RSU award denominated in shares of the Issuer's common stock. The number of shares underlying the RSU award will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian RSU award. Once the number of shares of the Issuer's common stock underlying this RSU award has been determined, an amended Form 4 will be filed disclosing such information. Each RSU represents a contingent right to receive one share of the Issuer's underlying common stock. F10 · derivative.exercise_date: These RSUs vest in two equal annual installments beginning on February 13, 2017. Vested shares will be delivered to the reporting person upon vest date. F10 · derivative.expiration_date: These RSUs vest in two equal annual installments beginning on February 13, 2017. Vested shares will be delivered to the reporting person upon vest date. F8 · derivative.underlying_shares: In connection with the Spin-off, each outstanding deferred stock unit ("RSU") award held by the reporting person was converted into a RSU award denominated in shares of the Issuer's common stock. The number of shares underlying the RSU award will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian RSU award. Once the number of shares of the Issuer's common stock underlying this RSU award has been determined, an amended Form 4 will be filed disclosing such information. Each RSU represents a contingent right to receive one share of the Issuer's underlying common stock. F8 · balance_after: In connection with the Spin-off, each outstanding deferred stock unit ("RSU") award held by the reporting person was converted into a RSU award denominated in shares of the Issuer's common stock. The number of shares underlying the RSU award will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian RSU award. Once the number of shares of the Issuer's common stock underlying this RSU award has been determined, an amended Form 4 will be filed disclosing such information. Each RSU represents a contingent right to receive one share of the Issuer's underlying common stock. Read SEC document
January 28, 2017 Filed Jan 31, 2017 21:03 UTC	Varex Imaging Corp VREX · Entity 5135	GrantRestricted Stock Units · Derivative	0	$0.00	$0.00	Disclosure SEC source: 0001214659-17-000583 · marketforms-37693.xml · derivative · entry 8 LaCasce Carl E. · CIK 0001695298 · SVP, Sales & Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · Not disclosed shares Expires not disclosed F8 · derivative.exercise_price: In connection with the Spin-off, each outstanding deferred stock unit ("RSU") award held by the reporting person was converted into a RSU award denominated in shares of the Issuer's common stock. The number of shares underlying the RSU award will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian RSU award. Once the number of shares of the Issuer's common stock underlying this RSU award has been determined, an amended Form 4 will be filed disclosing such information. Each RSU represents a contingent right to receive one share of the Issuer's underlying common stock. F8 · shares: In connection with the Spin-off, each outstanding deferred stock unit ("RSU") award held by the reporting person was converted into a RSU award denominated in shares of the Issuer's common stock. The number of shares underlying the RSU award will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian RSU award. Once the number of shares of the Issuer's common stock underlying this RSU award has been determined, an amended Form 4 will be filed disclosing such information. Each RSU represents a contingent right to receive one share of the Issuer's underlying common stock. F9 · derivative.exercise_date: These RSUs vest February 21, 2017. Vested shares will be delivered to the reporting person upon vest date. F9 · derivative.expiration_date: These RSUs vest February 21, 2017. Vested shares will be delivered to the reporting person upon vest date. F8 · derivative.underlying_shares: In connection with the Spin-off, each outstanding deferred stock unit ("RSU") award held by the reporting person was converted into a RSU award denominated in shares of the Issuer's common stock. The number of shares underlying the RSU award will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian RSU award. Once the number of shares of the Issuer's common stock underlying this RSU award has been determined, an amended Form 4 will be filed disclosing such information. Each RSU represents a contingent right to receive one share of the Issuer's underlying common stock. F8 · balance_after: In connection with the Spin-off, each outstanding deferred stock unit ("RSU") award held by the reporting person was converted into a RSU award denominated in shares of the Issuer's common stock. The number of shares underlying the RSU award will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian RSU award. Once the number of shares of the Issuer's common stock underlying this RSU award has been determined, an amended Form 4 will be filed disclosing such information. Each RSU represents a contingent right to receive one share of the Issuer's underlying common stock. Read SEC document
January 28, 2017 Filed Jan 31, 2017 21:03 UTC	Varex Imaging Corp VREX · Entity 5135	GrantRestricted Stock Units · Derivative	0	$0.00	$0.00	Disclosure SEC source: 0001214659-17-000583 · marketforms-37693.xml · derivative · entry 7 LaCasce Carl E. · CIK 0001695298 · SVP, Sales & Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · Not disclosed shares Expires not disclosed F8 · derivative.exercise_price: In connection with the Spin-off, each outstanding deferred stock unit ("RSU") award held by the reporting person was converted into a RSU award denominated in shares of the Issuer's common stock. The number of shares underlying the RSU award will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian RSU award. Once the number of shares of the Issuer's common stock underlying this RSU award has been determined, an amended Form 4 will be filed disclosing such information. Each RSU represents a contingent right to receive one share of the Issuer's underlying common stock. F8 · shares: In connection with the Spin-off, each outstanding deferred stock unit ("RSU") award held by the reporting person was converted into a RSU award denominated in shares of the Issuer's common stock. The number of shares underlying the RSU award will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian RSU award. Once the number of shares of the Issuer's common stock underlying this RSU award has been determined, an amended Form 4 will be filed disclosing such information. Each RSU represents a contingent right to receive one share of the Issuer's underlying common stock. F9 · derivative.exercise_date: These RSUs vest February 21, 2017. Vested shares will be delivered to the reporting person upon vest date. F9 · derivative.expiration_date: These RSUs vest February 21, 2017. Vested shares will be delivered to the reporting person upon vest date. F8 · derivative.underlying_shares: In connection with the Spin-off, each outstanding deferred stock unit ("RSU") award held by the reporting person was converted into a RSU award denominated in shares of the Issuer's common stock. The number of shares underlying the RSU award will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian RSU award. Once the number of shares of the Issuer's common stock underlying this RSU award has been determined, an amended Form 4 will be filed disclosing such information. Each RSU represents a contingent right to receive one share of the Issuer's underlying common stock. F8 · balance_after: In connection with the Spin-off, each outstanding deferred stock unit ("RSU") award held by the reporting person was converted into a RSU award denominated in shares of the Issuer's common stock. The number of shares underlying the RSU award will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian RSU award. Once the number of shares of the Issuer's common stock underlying this RSU award has been determined, an amended Form 4 will be filed disclosing such information. Each RSU represents a contingent right to receive one share of the Issuer's underlying common stock. Read SEC document
January 28, 2017 Filed Jan 31, 2017 21:03 UTC	Varex Imaging Corp VREX · Entity 5135	GrantNon-Qualified Stock Option (right to buy) · Derivative	0	$0.00	$0.00	Disclosure SEC source: 0001214659-17-000583 · marketforms-37693.xml · derivative · entry 6 LaCasce Carl E. · CIK 0001695298 · SVP, Sales & Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · Not disclosed shares Expires 2023-02-12 F1 · derivative.exercise_price: In connection with the Spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "Spin-off"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock. The number of shares underlying the option award, and the exercise price thereof, will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. Once the number of shares of the Issuer's common stock underlying this option award, and the exercise price thereof, has been determined, an amended Form 4 will be filed disclosing such information. F1 · shares: In connection with the Spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "Spin-off"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock. The number of shares underlying the option award, and the exercise price thereof, will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. Once the number of shares of the Issuer's common stock underlying this option award, and the exercise price thereof, has been determined, an amended Form 4 will be filed disclosing such information. F7 · derivative.exercise_date: Option is subject to a three year vesting schedule, 1/3 of the total number of shares vests in one year from February 12, 2016 and the remaining vests monthly thereafter. F1 · derivative.underlying_shares: In connection with the Spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "Spin-off"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock. The number of shares underlying the option award, and the exercise price thereof, will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. Once the number of shares of the Issuer's common stock underlying this option award, and the exercise price thereof, has been determined, an amended Form 4 will be filed disclosing such information. F1 · balance_after: In connection with the Spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "Spin-off"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock. The number of shares underlying the option award, and the exercise price thereof, will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. Once the number of shares of the Issuer's common stock underlying this option award, and the exercise price thereof, has been determined, an amended Form 4 will be filed disclosing such information. Read SEC document
January 28, 2017 Filed Jan 31, 2017 21:03 UTC	Varex Imaging Corp VREX · Entity 5135	GrantNon-Qualified Stock Option (right to buy) · Derivative	0	$0.00	$0.00	Disclosure SEC source: 0001214659-17-000583 · marketforms-37693.xml · derivative · entry 5 LaCasce Carl E. · CIK 0001695298 · SVP, Sales & Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · Not disclosed shares Expires 2022-02-13 F1 · derivative.exercise_price: In connection with the Spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "Spin-off"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock. The number of shares underlying the option award, and the exercise price thereof, will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. Once the number of shares of the Issuer's common stock underlying this option award, and the exercise price thereof, has been determined, an amended Form 4 will be filed disclosing such information. F1 · shares: In connection with the Spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "Spin-off"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock. The number of shares underlying the option award, and the exercise price thereof, will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. Once the number of shares of the Issuer's common stock underlying this option award, and the exercise price thereof, has been determined, an amended Form 4 will be filed disclosing such information. F6 · derivative.exercise_date: Option is subject to a three year vesting schedule, 1/3 of the total number of shares vests in one year from February 13, 2015 and the remaining vests monthly thereafter. F1 · derivative.underlying_shares: In connection with the Spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "Spin-off"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock. The number of shares underlying the option award, and the exercise price thereof, will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. Once the number of shares of the Issuer's common stock underlying this option award, and the exercise price thereof, has been determined, an amended Form 4 will be filed disclosing such information. F1 · balance_after: In connection with the Spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "Spin-off"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock. The number of shares underlying the option award, and the exercise price thereof, will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. Once the number of shares of the Issuer's common stock underlying this option award, and the exercise price thereof, has been determined, an amended Form 4 will be filed disclosing such information. Read SEC document
January 28, 2017 Filed Jan 31, 2017 21:03 UTC	Varex Imaging Corp VREX · Entity 5135	GrantNon-Qualified Stock Option (right to buy) · Derivative	0	$0.00	$0.00	Disclosure SEC source: 0001214659-17-000583 · marketforms-37693.xml · derivative · entry 4 LaCasce Carl E. · CIK 0001695298 · SVP, Sales & Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · Not disclosed shares Expires 2021-02-21 F1 · derivative.exercise_price: In connection with the Spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "Spin-off"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock. The number of shares underlying the option award, and the exercise price thereof, will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. Once the number of shares of the Issuer's common stock underlying this option award, and the exercise price thereof, has been determined, an amended Form 4 will be filed disclosing such information. F1 · shares: In connection with the Spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "Spin-off"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock. The number of shares underlying the option award, and the exercise price thereof, will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. Once the number of shares of the Issuer's common stock underlying this option award, and the exercise price thereof, has been determined, an amended Form 4 will be filed disclosing such information. F5 · derivative.exercise_date: Option is subject to a three year vesting schedule, 1/3 of the total number of shares vests in one year from February 21, 2014 and the remaining vests monthly thereafter. F1 · derivative.underlying_shares: In connection with the Spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "Spin-off"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock. The number of shares underlying the option award, and the exercise price thereof, will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. Once the number of shares of the Issuer's common stock underlying this option award, and the exercise price thereof, has been determined, an amended Form 4 will be filed disclosing such information. F1 · balance_after: In connection with the Spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "Spin-off"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock. The number of shares underlying the option award, and the exercise price thereof, will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. Once the number of shares of the Issuer's common stock underlying this option award, and the exercise price thereof, has been determined, an amended Form 4 will be filed disclosing such information. Read SEC document
January 28, 2017 Filed Jan 31, 2017 21:03 UTC	Varex Imaging Corp VREX · Entity 5135	GrantNon-Qualified Stock Option (right to buy) · Derivative	0	$0.00	$0.00	Disclosure SEC source: 0001214659-17-000583 · marketforms-37693.xml · derivative · entry 3 LaCasce Carl E. · CIK 0001695298 · SVP, Sales & Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · Not disclosed shares Expires 2019-11-09 F1 · derivative.exercise_price: In connection with the Spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "Spin-off"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock. The number of shares underlying the option award, and the exercise price thereof, will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. Once the number of shares of the Issuer's common stock underlying this option award, and the exercise price thereof, has been determined, an amended Form 4 will be filed disclosing such information. F1 · shares: In connection with the Spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "Spin-off"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock. The number of shares underlying the option award, and the exercise price thereof, will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. Once the number of shares of the Issuer's common stock underlying this option award, and the exercise price thereof, has been determined, an amended Form 4 will be filed disclosing such information. F4 · derivative.exercise_date: Option is subject to a three year vesting schedule, 1/3 of the total number of shares vests in one year from November 9, 2012 and the remaining vests monthly thereafter. F1 · derivative.underlying_shares: In connection with the Spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "Spin-off"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock. The number of shares underlying the option award, and the exercise price thereof, will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. Once the number of shares of the Issuer's common stock underlying this option award, and the exercise price thereof, has been determined, an amended Form 4 will be filed disclosing such information. F1 · balance_after: In connection with the Spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "Spin-off"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock. The number of shares underlying the option award, and the exercise price thereof, will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. Once the number of shares of the Issuer's common stock underlying this option award, and the exercise price thereof, has been determined, an amended Form 4 will be filed disclosing such information. Read SEC document
January 28, 2017 Filed Jan 31, 2017 21:03 UTC	Varex Imaging Corp VREX · Entity 5135	GrantNon-Qualified Stock Option (right to buy) · Derivative	0	$0.00	$0.00	Disclosure SEC source: 0001214659-17-000583 · marketforms-37693.xml · derivative · entry 2 LaCasce Carl E. · CIK 0001695298 · SVP, Sales & Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · Not disclosed shares Expires 2018-11-11 F1 · derivative.exercise_price: In connection with the Spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "Spin-off"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock. The number of shares underlying the option award, and the exercise price thereof, will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. Once the number of shares of the Issuer's common stock underlying this option award, and the exercise price thereof, has been determined, an amended Form 4 will be filed disclosing such information. F1 · shares: In connection with the Spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "Spin-off"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock. The number of shares underlying the option award, and the exercise price thereof, will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. Once the number of shares of the Issuer's common stock underlying this option award, and the exercise price thereof, has been determined, an amended Form 4 will be filed disclosing such information. F3 · derivative.exercise_date: Option is subject to a three year vesting schedule, 1/3 of the total number of shares vests in one year from November 11, 2011 and the remaining vests monthly thereafter F1 · derivative.underlying_shares: In connection with the Spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "Spin-off"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock. The number of shares underlying the option award, and the exercise price thereof, will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. Once the number of shares of the Issuer's common stock underlying this option award, and the exercise price thereof, has been determined, an amended Form 4 will be filed disclosing such information. F1 · balance_after: In connection with the Spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "Spin-off"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock. The number of shares underlying the option award, and the exercise price thereof, will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. Once the number of shares of the Issuer's common stock underlying this option award, and the exercise price thereof, has been determined, an amended Form 4 will be filed disclosing such information. Read SEC document
January 28, 2017 Filed Jan 31, 2017 21:03 UTC	Varex Imaging Corp VREX · Entity 5135	GrantNon-Qualified Stock Option (right to buy) · Derivative	0	$0.00	$0.00	Disclosure SEC source: 0001214659-17-000583 · marketforms-37693.xml · derivative · entry 1 LaCasce Carl E. · CIK 0001695298 · SVP, Sales & Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · Not disclosed shares Expires 2017-05-14 F1 · derivative.exercise_price: In connection with the Spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "Spin-off"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock. The number of shares underlying the option award, and the exercise price thereof, will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. Once the number of shares of the Issuer's common stock underlying this option award, and the exercise price thereof, has been determined, an amended Form 4 will be filed disclosing such information. F1 · shares: In connection with the Spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "Spin-off"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock. The number of shares underlying the option award, and the exercise price thereof, will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. Once the number of shares of the Issuer's common stock underlying this option award, and the exercise price thereof, has been determined, an amended Form 4 will be filed disclosing such information. F2 · derivative.exercise_date: Option is subject to a three year vesting schedule, 1/3 of the total number of shares vests in one year from May 14, 2010 and the remaining vests monthly thereafter F1 · derivative.underlying_shares: In connection with the Spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "Spin-off"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock. The number of shares underlying the option award, and the exercise price thereof, will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. Once the number of shares of the Issuer's common stock underlying this option award, and the exercise price thereof, has been determined, an amended Form 4 will be filed disclosing such information. F1 · balance_after: In connection with the Spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "Spin-off"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock. The number of shares underlying the option award, and the exercise price thereof, will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. Once the number of shares of the Issuer's common stock underlying this option award, and the exercise price thereof, has been determined, an amended Form 4 will be filed disclosing such information. Read SEC document
January 28, 2017 Filed Feb 9, 2017 21:02 UTC Amendment	Varex Imaging Corp VREX · Entity 5135	GrantRestricted Stock Units · Derivative	5,300	$0.00	$0.00	Disclosure SEC source: 0001214659-17-000915 · marketforms-37780.xml · derivative · entry 10 LaCasce Carl E. · CIK 0001695298 · SVP, Sales & Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,953 Underlying: Common Stock · 5,300 shares Expires 2020-02-15 F8 · derivative.exercise_price: In connection with the spin-off, each outstanding restricted stock unit ("RSU") award held by the reporting person was converted into a RSU award denominated in shares of the Issuer's common stock. The number of shares underlying the RSU award was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian RSU award. This amendment is being filed to disclose the number of shares of the Issuer's common stock underlying this RSU. Each RSU represents a contingent right to receive one share of the Issuer's underlying common stock. F8 · shares: In connection with the spin-off, each outstanding restricted stock unit ("RSU") award held by the reporting person was converted into a RSU award denominated in shares of the Issuer's common stock. The number of shares underlying the RSU award was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian RSU award. This amendment is being filed to disclose the number of shares of the Issuer's common stock underlying this RSU. Each RSU represents a contingent right to receive one share of the Issuer's underlying common stock. F11 · derivative.exercise_date: These RSUs vest in three equal annual installments beginning on February 15, 2017. Vested shares will be delivered to the reporting person upon vest date. F8 · derivative.underlying_shares: In connection with the spin-off, each outstanding restricted stock unit ("RSU") award held by the reporting person was converted into a RSU award denominated in shares of the Issuer's common stock. The number of shares underlying the RSU award was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian RSU award. This amendment is being filed to disclose the number of shares of the Issuer's common stock underlying this RSU. Each RSU represents a contingent right to receive one share of the Issuer's underlying common stock. F8 · balance_after: In connection with the spin-off, each outstanding restricted stock unit ("RSU") award held by the reporting person was converted into a RSU award denominated in shares of the Issuer's common stock. The number of shares underlying the RSU award was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian RSU award. This amendment is being filed to disclose the number of shares of the Issuer's common stock underlying this RSU. Each RSU represents a contingent right to receive one share of the Issuer's underlying common stock. Read SEC document
January 28, 2017 Filed Feb 9, 2017 21:02 UTC Amendment	Varex Imaging Corp VREX · Entity 5135	GrantRestricted Stock Units · Derivative	3,328	$0.00	$0.00	Disclosure SEC source: 0001214659-17-000915 · marketforms-37780.xml · derivative · entry 9 LaCasce Carl E. · CIK 0001695298 · SVP, Sales & Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,953 Underlying: Common Stock · 3,328 shares Expires 2019-02-15 F8 · derivative.exercise_price: In connection with the spin-off, each outstanding restricted stock unit ("RSU") award held by the reporting person was converted into a RSU award denominated in shares of the Issuer's common stock. The number of shares underlying the RSU award was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian RSU award. This amendment is being filed to disclose the number of shares of the Issuer's common stock underlying this RSU. Each RSU represents a contingent right to receive one share of the Issuer's underlying common stock. F8 · shares: In connection with the spin-off, each outstanding restricted stock unit ("RSU") award held by the reporting person was converted into a RSU award denominated in shares of the Issuer's common stock. The number of shares underlying the RSU award was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian RSU award. This amendment is being filed to disclose the number of shares of the Issuer's common stock underlying this RSU. Each RSU represents a contingent right to receive one share of the Issuer's underlying common stock. F10 · derivative.exercise_date: These RSUs vest in two equal annual installments beginning on February 15, 2017. Vested shares will be delivered to the reporting person upon vest date. F8 · derivative.underlying_shares: In connection with the spin-off, each outstanding restricted stock unit ("RSU") award held by the reporting person was converted into a RSU award denominated in shares of the Issuer's common stock. The number of shares underlying the RSU award was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian RSU award. This amendment is being filed to disclose the number of shares of the Issuer's common stock underlying this RSU. Each RSU represents a contingent right to receive one share of the Issuer's underlying common stock. F8 · balance_after: In connection with the spin-off, each outstanding restricted stock unit ("RSU") award held by the reporting person was converted into a RSU award denominated in shares of the Issuer's common stock. The number of shares underlying the RSU award was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian RSU award. This amendment is being filed to disclose the number of shares of the Issuer's common stock underlying this RSU. Each RSU represents a contingent right to receive one share of the Issuer's underlying common stock. Read SEC document
January 28, 2017 Filed Feb 9, 2017 21:02 UTC Amendment	Varex Imaging Corp VREX · Entity 5135	GrantRestricted Stock Units · Derivative	2,002	$0.00	$0.00	Disclosure SEC source: 0001214659-17-000915 · marketforms-37780.xml · derivative · entry 8 LaCasce Carl E. · CIK 0001695298 · SVP, Sales & Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,953 Underlying: Common Stock · 2,002 shares Expires 2018-02-15 F8 · derivative.exercise_price: In connection with the spin-off, each outstanding restricted stock unit ("RSU") award held by the reporting person was converted into a RSU award denominated in shares of the Issuer's common stock. The number of shares underlying the RSU award was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian RSU award. This amendment is being filed to disclose the number of shares of the Issuer's common stock underlying this RSU. Each RSU represents a contingent right to receive one share of the Issuer's underlying common stock. F8 · shares: In connection with the spin-off, each outstanding restricted stock unit ("RSU") award held by the reporting person was converted into a RSU award denominated in shares of the Issuer's common stock. The number of shares underlying the RSU award was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian RSU award. This amendment is being filed to disclose the number of shares of the Issuer's common stock underlying this RSU. Each RSU represents a contingent right to receive one share of the Issuer's underlying common stock. F9 · derivative.exercise_date: These RSUs vest February 15, 2017. Vested shares will be delivered to the reporting person upon vest date. F8 · derivative.underlying_shares: In connection with the spin-off, each outstanding restricted stock unit ("RSU") award held by the reporting person was converted into a RSU award denominated in shares of the Issuer's common stock. The number of shares underlying the RSU award was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian RSU award. This amendment is being filed to disclose the number of shares of the Issuer's common stock underlying this RSU. Each RSU represents a contingent right to receive one share of the Issuer's underlying common stock. F8 · balance_after: In connection with the spin-off, each outstanding restricted stock unit ("RSU") award held by the reporting person was converted into a RSU award denominated in shares of the Issuer's common stock. The number of shares underlying the RSU award was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian RSU award. This amendment is being filed to disclose the number of shares of the Issuer's common stock underlying this RSU. Each RSU represents a contingent right to receive one share of the Issuer's underlying common stock. Read SEC document
January 28, 2017 Filed Feb 9, 2017 21:02 UTC Amendment	Varex Imaging Corp VREX · Entity 5135	GrantRestricted Stock Units · Derivative	4,323	$0.00	$0.00	Disclosure SEC source: 0001214659-17-000915 · marketforms-37780.xml · derivative · entry 7 LaCasce Carl E. · CIK 0001695298 · SVP, Sales & Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,953 Underlying: Common Stock · 4,323 shares Expires 2018-02-15 F8 · derivative.exercise_price: In connection with the spin-off, each outstanding restricted stock unit ("RSU") award held by the reporting person was converted into a RSU award denominated in shares of the Issuer's common stock. The number of shares underlying the RSU award was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian RSU award. This amendment is being filed to disclose the number of shares of the Issuer's common stock underlying this RSU. Each RSU represents a contingent right to receive one share of the Issuer's underlying common stock. F8 · shares: In connection with the spin-off, each outstanding restricted stock unit ("RSU") award held by the reporting person was converted into a RSU award denominated in shares of the Issuer's common stock. The number of shares underlying the RSU award was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian RSU award. This amendment is being filed to disclose the number of shares of the Issuer's common stock underlying this RSU. Each RSU represents a contingent right to receive one share of the Issuer's underlying common stock. F9 · derivative.exercise_date: These RSUs vest February 15, 2017. Vested shares will be delivered to the reporting person upon vest date. F8 · derivative.underlying_shares: In connection with the spin-off, each outstanding restricted stock unit ("RSU") award held by the reporting person was converted into a RSU award denominated in shares of the Issuer's common stock. The number of shares underlying the RSU award was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian RSU award. This amendment is being filed to disclose the number of shares of the Issuer's common stock underlying this RSU. Each RSU represents a contingent right to receive one share of the Issuer's underlying common stock. F8 · balance_after: In connection with the spin-off, each outstanding restricted stock unit ("RSU") award held by the reporting person was converted into a RSU award denominated in shares of the Issuer's common stock. The number of shares underlying the RSU award was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian RSU award. This amendment is being filed to disclose the number of shares of the Issuer's common stock underlying this RSU. Each RSU represents a contingent right to receive one share of the Issuer's underlying common stock. Read SEC document
January 28, 2017 Filed Feb 9, 2017 21:02 UTC Amendment	Varex Imaging Corp VREX · Entity 5135	GrantNon-Qualified Stock Option (right to buy) · Derivative	14,703	$0.00 Strike: $25.17	$0.00	Disclosure SEC source: 0001214659-17-000915 · marketforms-37780.xml · derivative · entry 6 LaCasce Carl E. · CIK 0001695298 · SVP, Sales & Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,703 Underlying: Common Stock · 14,703 shares Expires 2023-02-12 F1 · shares: In connection with the spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "Spin-off"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock. The number of shares underlying the option award, and the exercise price thereof, was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. This amendment is being filed to disclose the exercise price and number of underlying shares that have been determined in respect of each grant. F7 · derivative.exercise_date: Option is subject to a three year vesting schedule, 1/3 of the total number of shares vests in one year from February 12, 2016 and the remaining vests monthly thereafter. F1 · derivative.underlying_shares: In connection with the spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "Spin-off"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock. The number of shares underlying the option award, and the exercise price thereof, was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. This amendment is being filed to disclose the exercise price and number of underlying shares that have been determined in respect of each grant. F1 · balance_after: In connection with the spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "Spin-off"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock. The number of shares underlying the option award, and the exercise price thereof, was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. This amendment is being filed to disclose the exercise price and number of underlying shares that have been determined in respect of each grant. Read SEC document
January 28, 2017 Filed Feb 9, 2017 21:02 UTC Amendment	Varex Imaging Corp VREX · Entity 5135	GrantNon-Qualified Stock Option (right to buy) · Derivative	12,472	$0.00 Strike: $30.74	$0.00	Disclosure SEC source: 0001214659-17-000915 · marketforms-37780.xml · derivative · entry 5 LaCasce Carl E. · CIK 0001695298 · SVP, Sales & Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,472 Underlying: Common Stock · 12,472 shares Expires 2022-02-13 F1 · shares: In connection with the spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "Spin-off"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock. The number of shares underlying the option award, and the exercise price thereof, was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. This amendment is being filed to disclose the exercise price and number of underlying shares that have been determined in respect of each grant. F6 · derivative.exercise_date: Option is subject to a three year vesting schedule, 1/3 of the total number of shares vests in one year from February 13, 2015 and the remaining vests monthly thereafter. F1 · derivative.underlying_shares: In connection with the spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "Spin-off"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock. The number of shares underlying the option award, and the exercise price thereof, was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. This amendment is being filed to disclose the exercise price and number of underlying shares that have been determined in respect of each grant. F1 · balance_after: In connection with the spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "Spin-off"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock. The number of shares underlying the option award, and the exercise price thereof, was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. This amendment is being filed to disclose the exercise price and number of underlying shares that have been determined in respect of each grant. Read SEC document
January 28, 2017 Filed Feb 9, 2017 21:02 UTC Amendment	Varex Imaging Corp VREX · Entity 5135	GrantNon-Qualified Stock Option (right to buy) · Derivative	13,790	$0.00 Strike: $27.77	$0.00	Disclosure SEC source: 0001214659-17-000915 · marketforms-37780.xml · derivative · entry 4 LaCasce Carl E. · CIK 0001695298 · SVP, Sales & Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,790 Underlying: Common Stock · 13,790 shares Expires 2021-02-21 F1 · shares: In connection with the spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "Spin-off"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock. The number of shares underlying the option award, and the exercise price thereof, was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. This amendment is being filed to disclose the exercise price and number of underlying shares that have been determined in respect of each grant. F5 · derivative.exercise_date: Option is subject to a three year vesting schedule, 1/3 of the total number of shares vests in one year from February 21, 2014 and the remaining vests monthly thereafter. F1 · derivative.underlying_shares: In connection with the spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "Spin-off"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock. The number of shares underlying the option award, and the exercise price thereof, was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. This amendment is being filed to disclose the exercise price and number of underlying shares that have been determined in respect of each grant. F1 · balance_after: In connection with the spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "Spin-off"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock. The number of shares underlying the option award, and the exercise price thereof, was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. This amendment is being filed to disclose the exercise price and number of underlying shares that have been determined in respect of each grant. Read SEC document
January 28, 2017 Filed Feb 9, 2017 21:02 UTC Amendment	Varex Imaging Corp VREX · Entity 5135	GrantNon-Qualified Stock Option (right to buy) · Derivative	13,530	$0.00 Strike: $22.84	$0.00	Disclosure SEC source: 0001214659-17-000915 · marketforms-37780.xml · derivative · entry 3 LaCasce Carl E. · CIK 0001695298 · SVP, Sales & Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,530 Underlying: Common Stock · 13,530 shares Expires 2019-11-09 F1 · shares: In connection with the spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "Spin-off"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock. The number of shares underlying the option award, and the exercise price thereof, was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. This amendment is being filed to disclose the exercise price and number of underlying shares that have been determined in respect of each grant. F4 · derivative.exercise_date: Option fully vested three years from date of grant. F1 · derivative.underlying_shares: In connection with the spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "Spin-off"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock. The number of shares underlying the option award, and the exercise price thereof, was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. This amendment is being filed to disclose the exercise price and number of underlying shares that have been determined in respect of each grant. F1 · balance_after: In connection with the spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "Spin-off"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock. The number of shares underlying the option award, and the exercise price thereof, was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. This amendment is being filed to disclose the exercise price and number of underlying shares that have been determined in respect of each grant. Read SEC document
January 28, 2017 Filed Feb 9, 2017 21:02 UTC Amendment	Varex Imaging Corp VREX · Entity 5135	GrantNon-Qualified Stock Option (right to buy) · Derivative	11,155	$0.00 Strike: $19.21	$0.00	Disclosure SEC source: 0001214659-17-000915 · marketforms-37780.xml · derivative · entry 2 LaCasce Carl E. · CIK 0001695298 · SVP, Sales & Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,155 Underlying: Common Stock · 11,155 shares Expires 2018-11-11 F1 · shares: In connection with the spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "Spin-off"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock. The number of shares underlying the option award, and the exercise price thereof, was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. This amendment is being filed to disclose the exercise price and number of underlying shares that have been determined in respect of each grant. F3 · derivative.exercise_date: Option fully vested three years from date of grant. F1 · derivative.underlying_shares: In connection with the spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "Spin-off"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock. The number of shares underlying the option award, and the exercise price thereof, was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. This amendment is being filed to disclose the exercise price and number of underlying shares that have been determined in respect of each grant. F1 · balance_after: In connection with the spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "Spin-off"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock. The number of shares underlying the option award, and the exercise price thereof, was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. This amendment is being filed to disclose the exercise price and number of underlying shares that have been determined in respect of each grant. Read SEC document
January 28, 2017 Filed Feb 9, 2017 21:02 UTC Amendment	Varex Imaging Corp VREX · Entity 5135	GrantNon-Qualified Stock Option (right to buy) · Derivative	18,089	$0.00 Strike: $17.53	$0.00	Disclosure SEC source: 0001214659-17-000915 · marketforms-37780.xml · derivative · entry 1 LaCasce Carl E. · CIK 0001695298 · SVP, Sales & Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,089 Underlying: Common Stock · 18,089 shares Expires 2017-05-14 F1 · shares: In connection with the spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "Spin-off"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock. The number of shares underlying the option award, and the exercise price thereof, was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. This amendment is being filed to disclose the exercise price and number of underlying shares that have been determined in respect of each grant. F2 · derivative.exercise_date: Option fully vested three years from date of grant. F1 · derivative.underlying_shares: In connection with the spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "Spin-off"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock. The number of shares underlying the option award, and the exercise price thereof, was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. This amendment is being filed to disclose the exercise price and number of underlying shares that have been determined in respect of each grant. F1 · balance_after: In connection with the spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "Spin-off"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock. The number of shares underlying the option award, and the exercise price thereof, was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. This amendment is being filed to disclose the exercise price and number of underlying shares that have been determined in respect of each grant. Read SEC document
January 20, 2017 Filed Nov 15, 2017 21:04 UTC	Varex Imaging Corp VREX · Entity 5135	GrantCommon Stock	6,328	$28.15	$178,133.20	Disclosure SEC source: 0001214659-17-006770 · marketforms-40122.xml · nonDerivative · entry 1 LaCasce Carl E. · CIK 0001695298 · SVP, Sales & Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,858 F1 · balance_after: These shares were acquired in connection with the company's separation from Varian Medical Systems, Inc. and were inadvertently omitted from column 5 in the Form 4 dated February 17, 2017. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.